TriLink BioTechnologies (TriLink, www.trilinkbiotech.com), a leading provider of custom nucleic acid-based products, today announced the launch of dilute-and-go primers for mitochondrial DNA (mtDNA) PCR amplification and sequencing in forensic identification, mitoPrimers[TM] (www.trilinkbiotech.com/mtDNAprimers). The high sensitivity of mtDNA PCR amplification and sequencing allows forensic scientists to obtain information from items of evidence associated with homicides or other criminal investigations, body identifications, cold cases and small pieces of evidence containing little biological material.
Standard mitoPrimers[TM] are now available from TriLink as stocked inventory in convenient pre-aliquotted dilute-and-go vials. TriLink's mitoPrimers[TM] are QC tested with certified standard reference materials. These features allow less in-house testing to assure quality by the end user. TriLink is the only commercial source of these QC tested primers, and also offers custom synthesis of other forensic mtDNA PCR amplification and sequencing primers and forensic mtDNA single-nucleotide polymorphism (SNP) assay primers.
"After learning from our customers that the high quality primers required in this extremely sensitive work were challenging to find in the market, we decided to invest in this area. With the expert advice of leading forensic scientist, Rhonda Roby we developed mitoPrimers[TM]. We are excited to have the opportunity to support mtDNA forensic analysis and will soon be releasing a mastermix product that will significantly improve the mtDNA PCR-sequencing workflow," stated TriLink CEO, Richard Hogrefe, Ph.D.
"We routinely use TriLink's mitoPrimers[TM] in our mitochondrial research," said Dr. Rhonda Roby, Associate Professor of Forensic and Investigative Genetics at UNT Health Science Center. "We've found them to be both cost-effective and convenient."
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp[TM] PCR products for the diagnostic and OEM markets. In addition, custom chemistry, long RNA and mRNA synthesis, contract research services and ISO/QSR compliant GMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 50 scientists and other professionals. For more information about the firm and products, visit our web site at www.trilinkbiotech.com`.